| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/25/2003 | CA2479153A1 Hybrid and single chain meganucleases and use thereof |
| 09/25/2003 | CA2479042A1 Cartilage regeneration using chondrocyte and tgf-.beta. |
| 09/25/2003 | CA2479007A1 Cells transfected with a nucleotide sequence encoding glp-1 and secreting insulin in a glucose-dependent manner |
| 09/25/2003 | CA2478651A1 Method of inducing an enhanced immune response against hiv |
| 09/25/2003 | CA2477828A1 Method of diagnosis and treatment of breast lesions |
| 09/24/2003 | EP1347055A2 Compounds for immunotherapy and diagnosis of tuberculosis |
| 09/24/2003 | EP1347042A1 A virus which can express tumor angiostatin factor with high efficiency in specific tumor cells and the use of it |
| 09/24/2003 | EP1346731A1 Conjugates for treating inflammatory disorders and associated tissue damage |
| 09/24/2003 | EP1346730A1 Pretargeting methods and novel pretargeting conjugates |
| 09/24/2003 | EP1346230A2 Screening method based on tsap6 binding partners |
| 09/24/2003 | EP1346218A1 Tripeptide of fc gama riia |
| 09/24/2003 | EP1346065A2 Antisense modulation of src-2 expression |
| 09/24/2003 | EP1346061A2 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 09/24/2003 | EP1346059A1 Photochemical internalization for delivery of molecules into the cytosol |
| 09/24/2003 | EP1346058A2 Adenoviral systems and the uses thereof |
| 09/24/2003 | EP1346053A2 Polynucleotides encoding human phosphatases |
| 09/24/2003 | EP1346047A2 Yeasts transformed by genes enhancing their cold stress tolerance |
| 09/24/2003 | EP1346045A1 Human protooncogene and protein encoded therein |
| 09/24/2003 | EP1346043A2 Compositions and methods relating to lung specific genes and proteins |
| 09/24/2003 | EP1346039A1 Human cervical cancer 2 protooncogene and protein encoded therein |
| 09/24/2003 | EP1346036A2 Helper virus-free herpes virus amplicon particles and uses thereof |
| 09/24/2003 | EP1345965A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 09/24/2003 | EP1345960A2 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau-r4 |
| 09/24/2003 | EP1345956A2 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 09/24/2003 | EP1345627A1 Targeted modification of intracellular compounds |
| 09/24/2003 | EP1345618A2 Use of intermediate-conductance potassium channels and modulators for the diagnosis and treatment of illnesses having disturbed keratinocyte activity |
| 09/24/2003 | EP1345617A2 Methods of modulating toll-related receptor (trr) signaling |
| 09/24/2003 | EP1345574A2 Improvement of graft acceptance through manipulation of thymic regeneration |
| 09/24/2003 | EP1345567A2 Calcium channel transport polynucleotides, polypeptides, and antibodies |
| 09/24/2003 | EP1117428B1 Compositions and their use for inhibiting angiogenesis |
| 09/24/2003 | EP0918509B1 Biocompatible devices with foam scaffolds |
| 09/24/2003 | CN1444661A Method for detecting growth hormone variations in humans, the variations and their uses |
| 09/24/2003 | CN1444650A Pseudo-type retrovirus vector containing membrane protein having hemagglutinin activity |
| 09/24/2003 | CN1444601A Regulating lipid levels via the Zmaxl or HBM gene |
| 09/24/2003 | CN1444486A Use of interferon receptor 2c polypeptide chain to enhance anti-growth effects of type I interferons |
| 09/24/2003 | CN1444472A Plasmid DNA (Lipogenes TM) and nucleas-containing location signal/fusogene conjogates drug encapsulating into targeted liposomes complex |
| 09/24/2003 | CN1122040C Suger modified nucleosides and their use of synthesis of oligonucleotide |
| 09/23/2003 | US6624149 Using transition metal compound promoter |
| 09/23/2003 | US6623961 Method for selective inactivation of viral replication |
| 09/23/2003 | US6623958 Compositions and methods for non-targeted activation of endogenous genes |
| 09/23/2003 | US6623952 Infectious; of given sequence; may be used as a vector for gene therapy, in a vaccine or for detection of viruses for xenotransplantation |
| 09/23/2003 | US6623951 HBV vectors and cells for producing the same |
| 09/23/2003 | US6623942 Nucleotide sequences coding polypetide for use in treatment of hematopoietic and immunological disorders; wound healing agents |
| 09/23/2003 | US6623925 Screening for a test compound that affects the ability of DNA to bind to protein or affects the expression of reporter molecule; use for gene therapy |
| 09/23/2003 | US6623923 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 09/23/2003 | CA2101332C Antibody polycation conjugates |
| 09/18/2003 | WO2003076950A2 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders |
| 09/18/2003 | WO2003076948A1 Use of the mal protein as a tumour marker |
| 09/18/2003 | WO2003076646A2 Identification and tissue distribution of two novel spliced variants of the mouse lats2 gene |
| 09/18/2003 | WO2003076634A2 Transcriptional regulation of ptp-1b |
| 09/18/2003 | WO2003076631A2 Genetic products differentially expressed in tumors and use thereof |
| 09/18/2003 | WO2003076620A1 Methods and means for monitoring and modulating gene silencing |
| 09/18/2003 | WO2003076609A1 Rhomboid-related protein |
| 09/18/2003 | WO2003076605A1 A method for producing recombinant viruses using site-specific recombination |
| 09/18/2003 | WO2003076596A2 Altering viral tropism |
| 09/18/2003 | WO2003076594A2 Genomic screen for epigenetically silenced tumor suppressor genes |
| 09/18/2003 | WO2003076593A2 Genomic screen for epigenetically silenced genes associated with cancer |
| 09/18/2003 | WO2003076592A2 Novel method for delivery and intracellular synthesis of sirna molecules |
| 09/18/2003 | WO2003076591A2 Compositions and methods for generating an immune response |
| 09/18/2003 | WO2003076575A2 The complete genome and protein sequence of the hyperthermophile methanopyrus kandleri av19 and monophyly of archael methanogens and methods of use thereof |
| 09/18/2003 | WO2003076565A2 Methods of using 46828, a human acyl-coa synthetase |
| 09/18/2003 | WO2003076468A1 Novel therapeutic composition for the prevention and treatment of hiv-1 infection in humans |
| 09/18/2003 | WO2003076467A1 Compositions and methods for inducing and regulating bone formation |
| 09/18/2003 | WO2003075952A1 Methods of enhancing immune induction involving mda-7 |
| 09/18/2003 | WO2003075951A2 Novel application of vaccination against tnf-alpha |
| 09/18/2003 | WO2003075948A1 NOVEL FUNCTION OF Wnt AND APPLICATION THEREOF TO TREATMENT OF DISEASES |
| 09/18/2003 | WO2003075945A2 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis |
| 09/18/2003 | WO2003075925A1 Methods for reducing body fat and increasing a lean body mass by reducing stearoyl-coa desaturase 1 activity |
| 09/18/2003 | WO2003075888A2 Materials containing multiple layers of vesicles |
| 09/18/2003 | WO2003075856A2 Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea |
| 09/18/2003 | WO2003075843A2 Multiple and multivalent dna vaccines in ovo |
| 09/18/2003 | WO2003049700A3 Growth hormone releasing hormone suplementation for treating chronically ill subjects |
| 09/18/2003 | WO2003046135A3 Osteopontin-related compositions and methods |
| 09/18/2003 | WO2003035861A3 Thrombin-cleavable chimeric proteins |
| 09/18/2003 | WO2003035105A3 A synthetic chimeric fusion protein with immuno-therapeutic uses |
| 09/18/2003 | WO2003033692A3 Use of the adenoviral e2 late promoter |
| 09/18/2003 | WO2003031584A3 Axon repair |
| 09/18/2003 | WO2003026584A3 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 09/18/2003 | WO2003025191A3 Pseudotyped retroviral vector system |
| 09/18/2003 | WO2003008599A3 System for producing clonal or complex populations of recombinant adenoviruses, and the application of the same |
| 09/18/2003 | WO2002097125A3 Tools for the diagnosis, molecular definition and development of treatment of chronic inflammatory joint diseases |
| 09/18/2003 | WO2002094868A3 Staphylococcus aureus proteins and nucleic acids |
| 09/18/2003 | WO2002085410A3 Method for evaluating the efficacy of treatment with bacterial dna and bacterial cell walls |
| 09/18/2003 | WO2002083184A3 Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis |
| 09/18/2003 | WO2002080982A3 Nucleic acid mucosal immunization |
| 09/18/2003 | WO2002077267A3 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon |
| 09/18/2003 | WO2002072790A3 Tsg101-gag interaction and use thereof |
| 09/18/2003 | WO2002072027A3 Oncolytic rna replicons |
| 09/18/2003 | WO2002066646A3 Neurotransmission-associated proteins |
| 09/18/2003 | WO2002036810A3 Antisense modulation of talin expression |
| 09/18/2003 | WO2002029056A3 Mini-dystrophin nucleic acid and peptide sequences |
| 09/18/2003 | WO2002007757A3 Prevention and treatment of sexual arousal disorders |
| 09/18/2003 | US20030177511 Antitumor, anticancer agents |
| 09/18/2003 | US20030176686 Diagnosis, therapy; animal growth regulators; controlling cell differentiation; antiiinflammatory agents, antihistamines, Crohn's disease, anticancer agents, autoimmune disease |
| 09/18/2003 | US20030176678 Viricides, antitumor agents, antiproliferative agents, anticancer agents; genetic engineered Dna |
| 09/18/2003 | US20030176672 Compositions and methods relating to breast specific genes and proteins |
| 09/18/2003 | US20030176666 Hypothalamus-specific polypeptides |
| 09/18/2003 | US20030176661 Novel antibody with specificity for colon cancer |
| 09/18/2003 | US20030176659 Adipocyte-specific protein homologs |
| 09/18/2003 | US20030176658 Adipocyte-specific protein homologs |